$CELG Company News Nasdaq needs to turn up the volume

New Post Public Reply Private Reply Replies (0) Message Board

Jul 22, 2014 at 11:20 AM

$CELG Company News

Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Bull rolls on, but opportunities start to dwindle 1:52 p.m. July 10, 2014 - The Trading Deck
Reynolds rises on buyout report; Delta gains altitude 2:25 p.m. July 9, 2014 - Sue Chang
Celgene's arthritis drug fails a test, but company's stock rises anyway 1:23 p.m. July 9, 2014 - Russ Britt
Celgene shares slump as late-stage trial misses goal 7:27 a.m. July 9, 2014 - Ciara Linnane
S&P, Dow rattle cage on uncharted territory 11:20 a.m. July 1, 2014 - Michael Ashbaugh
S&P, Dow rattle cage on uncharted territory 10:54 a.m. July 1, 2014 - Michael Ashbaugh
Celgene's fourth stock split is a hit with investors as shares climb 1:02 p.m. June 19, 2014 - Russ Britt
Celgene shareholders approve 2-for-1 stock split 8:57 a.m. June 19, 2014 - Ciara Linnane
Celgene to increase buyback program to 1.15 bln shares from 575 mln 8:52 a.m. June 19, 2014 - Ciara Linnane
Celgene shareholders approve 2-for-1 stock split 8:51 a.m. June 19, 2014 - Ciara Linnane
Celgene drops 1.9%, among worst S&P 500 losers 9:32 a.m. May 29, 2014 - Sue Chang
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Sue Chang
What ‘Game of Thrones’ can teach you about money 8:30 a.m. April 5, 2014 - Wallace Witkowski
Biotechs, bonds and more from the 'tempest in a microsecond' 8:32 a.m. April 2, 2014 - Shawn Langlois
Play-it-safe stock investors may take some risk on jobs 8:31 a.m. March 30, 2014 - Wallace Witkowski
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com

Top Biotech Picks for Q2 Earnings 12 min ago - Barrons.com
Biogen Shares Rebound As Street Has A Change Of Heart 3:09 p.m. July 21, 2014 - Investors Business Daily
Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More? 10:40 a.m. July 21, 2014 - Seeking Alpha
Top Biotech Earnings Previews for the Week Ahead 8:17 a.m. July 20, 2014 - 247WallSt.com
IBD 50 Ends Week Lower But Skyworks Soars 5:47 p.m. July 18, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: COP, CELG, AXP 3:59 p.m. July 18, 2014 - TheStreet.com
Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings 8:30 a.m. July 18, 2014 - 247WallSt.com
Today's Market: Tech, Biotech And Social Media Stocks In The News 10:53 a.m. July 16, 2014 - Seeking Alpha
UPDATE: Morgan Stanley Reiterates On Celgene As EU Patents Risk May Be Underappreciated 9:50 a.m. July 16, 2014 - benzinga.com
Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog 9:49 a.m. July 16, 2014 - Zacks.com
Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron 9:42 a.m. July 16, 2014 - Seeking Alpha
Q2 2014 Update: My Whistler Income And Growth Portfolio 2:24 p.m. July 15, 2014 - Seeking Alpha
Yellen Swats Down Biotech, Social Media Stocks 12:57 p.m. July 15, 2014 - FOXBusiness
Will Johnson & Johnson (JNJ) Beat this Earnings Season? - Analyst Blog 4:45 p.m. July 14, 2014 - Zacks.com
Why Pharma Is Flocking to Inversions 1:53 p.m. July 14, 2014 - The Wall Street Journal Interactive Edition
ABBV, BIIB And CELG, Pushing Drugs Industry Downward 1:03 p.m. July 14, 2014 - TheStreet.com
Hefty Price Tag of Gilead's Sovaldi Questioned Again - Analyst Blog 11:30 a.m. July 14, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MDLZ, BMY, CELG 9:59 a.m. July 14, 2014 - TheStreet.com
3 Biotech Stocks That Belong in Your Portfolio 4:45 a.m. July 14, 2014 - InvestorPlace.com
A Contrarian's Take 2:07 a.m. July 12, 2014 - Barrons.com

Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis 7:00 a.m. July 9, 2014 - BusinessWire - BZX
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
Clinical Trials, Petitions, and Upcoming Earnings Releases - Analyst Notes on Celgene, Covidien, AbbVie, Teva and Thermo Fisher Scientific 5:40 a.m. July 8, 2014 - PR Newswire - PRF
Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014 8:31 a.m. July 1, 2014 - BusinessWire - BZX
CORRECTING and REPLACINGCelgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake 2:28 p.m. June 26, 2014 - BusinessWire - BZX
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before 9:37 a.m. June 26, 2014 - ACCESSWIRE
Celgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake 8:30 a.m. June 26, 2014 - BusinessWire - BZX
Celgene Stockholders Approve Two-for-One Stock Split 8:30 a.m. June 19, 2014 - BusinessWire - BZX
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA 8:58 a.m. June 14, 2014 - BusinessWire - BZX
Studies Presented at 19th European Hematology Association Annual Congress Evaluate Activin Receptor Ligand Trap Programs in Beta-Thalassemia 3:00 a.m. June 14, 2014 - BusinessWire - BZX
Analysis of Health-Related Quality of Life Measures from the MM-020/IFM 07-01 (FIRST®) Trial Presented at EHA Annual Congress 5:44 p.m. June 13, 2014 - BusinessWire - BZX
Critical Alerts For JC Penney, Brown Forman, Schlumberger, Celgene, and DirecTV Technology Released By InvestorsObserver 9:31 a.m. June 11, 2014 - PR Newswire - PRF
Oral OTEZLA® (Apremilast) Showed Long-Term Clinical Benefits in Patients with Active Psoriatic Arthritis 7:30 a.m. June 11, 2014 - BusinessWire - BZX
Oral OTEZLA® (Apremilast) Monotherapy Showed Long-Term Clinical Benefits in DMARD-Naïve Patients with Active Psoriatic Arthritis 7:30 a.m. June 11, 2014 - BusinessWire - BZX
Health Care Sector Equities Coverage -- Research on Neurocrine Biosciences, PDL BioPharma, Celgene, and Array BioPharma 7:50 a.m. June 6, 2014 - PR Newswire - PRF
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 9:01 a.m. June 1, 2014 - BusinessWire - BZX
Veracyte, Foundation Medicine and Panacea Global Paving Way in Faster, More Accurate Cancer Diagnostics 9:53 a.m. May 29, 2014 - ACCESSWIRE
Breakthrough Innovation for Animal Health, Upcoming Conference Presentations, and New Treatment Options for Patients - Analyst Notes on Merck, Actavis, Celgene, Bristol-Myers Squibb and GSK 5:50 a.m. May 29, 2014 - PR Newswire - PRF
Organizational Changes Strengthen and Expand Celgene Leadership Team 6:00 a.m. May 22, 2014 - BusinessWire - BZX
Marketing Authorizations, Study Results Presentations, FDA Response to Drug Application, and New Messaging Services - Analyst Notes on Johnson & Johnson, Merck, Celgene, Novartis and UnitedHealth 8:41 a.m. May 21, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Backroads Invites Families: Adventures Boost Bookings by 20%

Rediscovering Family Time Through Adventure When was the last time a winter vacation got you this fired up? Backroads, the trailblazer in active getaways, is bucking the trend of typical holiday madness. Families are ditching the usual gift-giving grind for something way more memorable: experiences that blend action with bonding across generations. Big Numbers, Big...

Counterfeits in Aerospace: Industry Tackles Supply Risks

The Trouble with Counterfeit Parts in Aerospace Ah, aerospace—the domain where milliseconds matter, and materials must be tougher than a New York steelworker's boots. But guess what's throwing a wrench in the works? Counterfeit parts. That's right, the sector's latest buzzkill is as sneaky as a penny stock scam, and it's about time the industry's heavyweights had a...

mainelove Rides High With Double Gold and Growth

mainelove Shakes Up the Water Scene Well ain't that a splash? mainelove, the Maine-sourced water outfit, just snagged itself some shiny Double Gold hardware at the 2026 Water Choice Awards. Makes you raise a glass—or a can, I suppose—to see a local brand licking its chops over a win like this. It's not every day you hear a water company nailing it across state lines,...

Worldline Crowned as 2026 SPARK Matrix Leader

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...

Clean Energy Ventures Taps Ramsamy as Managing Partner

Welcome to the New Guard at CEV There's a new sheriff in town at Clean Energy Ventures (CEV), and her name is Aruna Ramsamy. On a brisk day in Boston, the venture capital firm made waves by announcing Ramsamy as their new Managing Partner, a move designed to light up their European operations and ramp up investments in climate technologies. They're not just talking the...

Vero Beach's Soaring Popularity: A Real Estate Surge?

Vero Beach: A Rising Star in Travel Trends Who would've thought Vero Beach, that quiet escape with a nod to old-school Florida, would suddenly find itself in the spotlight? Skyscanner's Travel Trends report thrusts this charming coastal town to the top of the list for 2027, ahead of hotspots like Bimini and Olbia. An impressive 201% increase in flight searches has...

2026 World Laureates Forum Drives Science Forward

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

National CORE Retains A+ Rating as Housing Demand Soars

A Rating That Speaks Volumes in Affordable Housing Fresh out of Rancho Cucamonga, National CORE's announcement of its A+ credit rating reaffirmation is no small potatoes. For the fourth consecutive year, Standard & Poor's Global Ratings has found that this nonprofit affordable housing developer checks all the right boxes for financial strength and strategic prowess. It's...

Encompass Health Eyes Houston Growth with New Hospital

Fort Bend County: The Next Step in Encompass Health's Journey Kicking off with some Texas flair, Encompass Health is making notable moves in Fort Bend County, venturing to boost its presence in the greater Houston area. It's no surprise given that this neck of the woods is seeing quite the growth spurt lately. Encompass Health, no stranger to living large, is charting new...

Diplomats Immerse in Xi'an's Rich History and Culture

Embarking on Shaanxi's Cultural Odyssey You think you've seen culture until you get a whiff of Shaanxi’s rich tapestry. From October 9 to 12, diplomats from Belarus, Morocco, Albania, and six other nations took a deep dive into China’s vibrant history and arts at the 'Discover China Cultural Tour.' Forget the usual conference room drudgery—this was all about getting...